Pay in 4 interest-free payments of $5.59 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Smaller contributions from cardiovascular and endocrinology specialists may reflect patients with more complex cardiometabolic profiles
Gilman CP, Perry T, Furukawa K, Grieg NH, Egan JM, Mattson MP
Mechanism of Action Tirzepatide, which acts as an agonist for both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, addresses OSA through its profound effects on weight reduction and metabolic improvement
(12) Stefan M, et al
Accepted clinical thresholds prioritize BMI and related conditions: a BMI 30 typically meets criteria for pharmacologic therapy, while a BMI 27 with qualifying comorbidities may also be eligible
US$ 21.54
US$ 25.59
US$ 21.50
US$ 28.43
US$ 24.25
US$ 29.36
US$ 23.97
US$ 21.19
US$ 29.87
US$ 27.83
US$ 22.11
US$ 29.07
US$ 21.33
